Jason A. Leverone Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

RPHM Quotes by TradingView

Jason A. Leverone is Chief Financial Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 12,906 shares of RPHM, which is worth approximately $21,682. The most recent transaction as insider was on Jun 23, 2025, when has been sold 303 shares (Class A Common Stock) at a price of $2.38 per share, resulting in proceeds of $721. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.9K
14.26% 3M change
n/a 12M change
Total Value Held $21,682

Jason A. Leverone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2025
SELL
Open market or private sale
$721 $2.38 p/Share
303 Reduced 2.29%
12,906 Class A Common Stock
Apr 07 2025
SELL
Open market or private sale
$4,923 $2.67 p/Share
1,844 Reduced 12.25%
13,209 Class A Common Stock
Apr 04 2025
SELL
Open market or private sale
$4,255 $3.33 p/Share
1,278 Reduced 7.83%
15,053 Class A Common Stock
Oct 04 2024
BUY
Grant, award, or other acquisition
-
16,331 Added 50.0%
16,331 Class A Common Stock

Also insider at

VRDN
Viridian Therapeutics, Inc.\DE Healthcare
Chief Financial Officer
JAL

Jason A. Leverone

Chief Financial Officer
Boulder, CO

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPHM